Skip to Main content
Number of documents

68

David Blum


Journal articles66 documents

  • Victoria Gomez-Murcia, Kevin Carvalho, Bryan Thiroux, Raphaëlle Caillierez, Melanie Besegher, et al.. Impact of chronic doxycycline treatment in the APP/PS1 mouse model of Alzheimer's disease. Neuropharmacology, Elsevier, 2022, 209, pp.108999. ⟨10.1016/j.neuropharm.2022.108999⟩. ⟨inserm-03699325⟩
  • Ouada Nebie, Luc Buée, David Blum, Thierry Burnouf. Can the administration of platelet lysates to the brain help treat neurological disorders?. Cellular and Molecular Life Sciences, Springer Verlag, 2022, 79 (7), pp.379. ⟨10.1007/s00018-022-04397-w⟩. ⟨hal-03706616⟩
  • Matthieu Rousset, Sandrine Humez, Cyril Laurent, Luc Buée, David Blum, et al.. Mammalian Brain Ca2+ Channel Activity Transplanted into Xenopus laevis Oocytes. Membranes, MDPI, 2022, 12 (5), pp.496. ⟨10.3390/membranes12050496⟩. ⟨inserm-03699305⟩
  • Eléonore Bertin, Audrey Martinez, Anne Fayoux, Kevin Carvalho, Sara Carracedo, et al.. Increased surface P2X4 receptors by mutant SOD1 proteins contribute to ALS pathogenesis in SOD1-G93A mice. Cellular and Molecular Life Sciences, Springer Verlag, 2022, 79 (8), pp.431. ⟨10.1007/s00018-022-04461-5⟩. ⟨hal-03727881⟩
  • Lee-Hsin Wang, Chien-Yu Lin, Yu-Mei Lin, Luc Buée, Nicolas Sergeant, et al.. Calpain-2 Mediates MBNL2 Degradation and a Developmental RNA Processing Program in Neurodegeneration. Journal of Neuroscience, Society for Neuroscience, 2022, pp.JN-RM-2006-21. ⟨10.1523/JNEUROSCI.2006-21.2022⟩. ⟨inserm-03699311⟩
  • Ching-Pang Chang, Ya-Gin Chang, Pei-Yun Chuang, Thi Ngoc Anh Nguyen, Kuo-Chen Wu, et al.. Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathy. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2021, 9 (1), pp.112. ⟨10.1186/s40478-021-01213-7⟩. ⟨inserm-03366697⟩
  • Ouada Nebie, Kevin Carvalho, Lassina Barro, Liling Delila, Emilie Faivre, et al.. Human platelet lysate biotherapy for traumatic brain injury: preclinical assessment. Brain - A Journal of Neurology , Oxford University Press (OUP), 2021, pp.awab205. ⟨10.1093/brain/awab205⟩. ⟨inserm-03366711⟩
  • Kevin Carvalho, Elodie Martin, Aurélia Ces, Nadège Sarrazin, Pauline Lagouge-Roussey, et al.. P2X7-deficiency improves plasticity and cognitive abilities in a mouse model of Tauopathy. Progress in Neurobiology, Elsevier, 2021, 206, pp.102139. ⟨10.1016/j.pneurobio.2021.102139⟩. ⟨inserm-03366671⟩
  • Iain Hartnell, David Blum, James Nicoll, Guillaume Dorothee, Delphine Boche. Glial cells and adaptive immunity in frontotemporal dementia with tau pathology. Brain - A Journal of Neurology , Oxford University Press (OUP), 2021, 144 (3), pp.724-745. ⟨10.1093/brain/awaa457⟩. ⟨hal-03156966⟩
  • Philibert Duriez, Sabiha Eddarkaoui, David Blum, Suzanne L Dickson, Philip Gorwood, et al.. Does physical activity associated with chronic food restriction alleviate anxiety like behaviour, in female mice?. Hormones and Behavior, Elsevier, 2020, 124, pp.104807. ⟨10.1016/j.yhbeh.2020.104807⟩. ⟨inserm-03048737⟩
  • Annerieke Sierksma, Ashley Lu, Renzo Mancuso, Nicola Fattorelli, Nicola Thrupp, et al.. Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology. EMBO Molecular Medicine, Wiley Open Access, 2020, pp.e10606. ⟨10.15252/emmm.201910606⟩. ⟨inserm-02450349⟩
  • Tariq Ahmed, Ann van Der Jeugd, Raphaëlle Caillierez, Luc Buée, David Blum, et al.. Chronic Sodium Selenate Treatment Restores Deficits in Cognition and Synaptic Plasticity in a Murine Model of Tauopathy. Frontiers in Molecular Neuroscience, Frontiers Media, 2020, 13, pp.570223. ⟨10.3389/fnmol.2020.570223⟩. ⟨inserm-02999926⟩
  • Victoria Gomez-Murcia, Ursula Sandau, Barbara Ferry, Sandrine Parrot, Cyril Laurent, et al.. Hyperexcitability and seizures in the THY-Tau22 mouse model of tauopathy. Neurobiology of Aging, Elsevier, 2020, 94, pp.265-270. ⟨10.1016/j.neurobiolaging.2020.06.004⟩. ⟨hal-03065490⟩
  • Laetitia Degiorgis, Meltem Karatas, Marion Sourty, Emilie Faivre, Julien Lamy, et al.. Brain network remodelling reflects tau-related pathology prior to memory deficits in Thy-Tau22 mice. Brain - A Journal of Neurology , Oxford University Press (OUP), 2020, ⟨10.1093/brain/awaa312⟩. ⟨hal-03086057⟩
  • Ouada Nebie, Lassina Barro, Yu-Wen Wu, Folke Knutson, Luc Buee, et al.. Heat-treated human platelet pellet lysate modulates microglia activation, favors wound healing and promotes neuronal differentiation in vitro. Platelets, Taylor & Francis, 2020, 1, pp.1-12. ⟨10.1080/09537104.2020.1732324⟩. ⟨hal-02541219⟩
  • Eric Boué-Grabot, David Blum, Stefania Ceruti. Editorial: Purinergic Signaling in Health and Disease. Frontiers in Cellular Neuroscience, Frontiers, 2020, 14, ⟨10.3389/fncel.2020.00015⟩. ⟨hal-02541233⟩
  • Enrico Faldini, Tariq Ahmed, Luc Buée, David Blum, Detlef Balschun. Tau- but not Aß -pathology enhances NMDAR-dependent depotentiation in AD-mouse models. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2019, 7 (1), pp.202. ⟨10.1186/s40478-019-0813-4⟩. ⟨hal-02413632⟩
  • Stefania Zappettini, Emilie Faivre, Antoine Ghestem, Sébastien Carrier, Luc Buee, et al.. Caffeine Consumption During Pregnancy Accelerates the Development of Cognitive Deficits in Offspring in a Model of Tauopathy. Frontiers in Cellular Neuroscience, Frontiers, 2019, 13, pp.438. ⟨10.3389/fncel.2019.00438⟩. ⟨inserm-02348452⟩
  • Antoine Leboucher, Tariq Ahmed, Emilie Caron, Anne Tailleux, Sylvie Raison, et al.. Brain insulin response and peripheral metabolic changes in a Tau transgenic mouse model. Neurobiology of Disease, Elsevier, 2019, 125, pp.14-22. ⟨10.1016/j.nbd.2019.01.008⟩. ⟨inserm-02350072⟩
  • Isabel Paiva, Kévin Carvalho, Patricia R. Santos, Lucrezia Cellai, Maria Angeliki S. Pavlou, et al.. A2A R‐induced transcriptional deregulation in astrocytes: An in vitro study. Glia, Wiley, 2019, 67 (12), pp.2329-2342. ⟨10.1002/glia.23688⟩. ⟨inserm-02350068⟩
  • Nicolas Sergeant, Valérie Vingtdeux, Sabiha Eddarkaoui, Marion Gay, Caroline Evrard, et al.. New piperazine multi-effect drugs prevent neurofibrillary degeneration and amyloid deposition, and preserve memory in animal models of Alzheimer's disease. Neurobiology of Disease, Elsevier, 2019, 129, pp.217-233. ⟨10.1016/j.nbd.2019.03.028⟩. ⟨inserm-02350071⟩
  • Ouada Nebie, David Devos, Valérie Vingtdeux, Lassina Barro, Jean-Christophe Devedjian, et al.. The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates. Journal of Biomedical Science, BioMed Central, 2019, 26 (1), pp.89. ⟨10.1186/s12929-019-0579-9⟩. ⟨inserm-02348443⟩
  • Amina Chaalal, Roseline Poirier, David Blum, Serge Laroche, Valérie Enderlin. Thyroid Hormone Supplementation Restores Spatial Memory, Hippocampal Markers of Neuroinflammation, Plasticity-Related Signaling Molecules, and β-Amyloid Peptide Load in Hypothyroid Rats. Molecular Neurobiology, Humana Press, 2019, 56 (1), pp.722-735. ⟨10.1007/s12035-018-1111-z⟩. ⟨inserm-01833290⟩
  • Christina Ising, Carmen Venegas, Shuangshuang Zhang, Hannah Scheiblich, Susanne Schmidt, et al.. NLRP3 inflammasome activation drives tau pathology. Nature, Nature Publishing Group, 2019, 575 (7784), pp.669-673. ⟨10.1038/s41586-019-1769-z⟩. ⟨hal-02413609⟩
  • Kevin Carvalho, Emilie Faivre, Marie Pietrowski, Xavier Marques, Victoria Gomez-Murcia, et al.. Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor. Brain - A Journal of Neurology , Oxford University Press (OUP), 2019, 142 (11), pp.3636-3654. ⟨10.1093/brain/awz288⟩. ⟨inserm-02350065⟩
  • Stefania Zappettini, Emilie Faivre, Antoine Ghestem, Sébastien Carrier, Luc Buee, et al.. Caffeine Consumption During Pregnancy Accelerates the Development of Cognitive Deficits in Offspring in a Model of Tauopathy. Frontiers in Cellular Neuroscience, Frontiers, 2019, 13, pp.438. ⟨10.3389/fncel.2019.00438⟩. ⟨inserm-02350061⟩
  • Ouada Nebie, David Devos, Valérie Vingtdeux, Lassina Barro, Jean-Christophe Devedjian, et al.. The neuroprotective activity of heat-treated human platelet lysate biomaterials manufactured from outdated pathogen-reduced (amotosalen/UVA) platelet concentrates. Journal of Biomedical Science, BioMed Central, 2019, 26 (1), pp.89. ⟨10.1186/s12929-019-0579-9⟩. ⟨inserm-02350063⟩
  • Andrea Popelová, Veronika Pražienková, Barbora Neprašová, Barbora Judita Kasperová, Lucie Hrubá, et al.. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy. Journal of Alzheimer's Disease, IOS Press, 2018, 62 (4), pp.1725 - 1736. ⟨10.3233/JAD-171041⟩. ⟨inserm-01833299⟩
  • Aurélie Joly-Amado, Maud Gratuze, Hamza Benderradji, Didier D. Vieau, Luc Buee, et al.. [Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies]. médecine/sciences, EDP Sciences, 2018, 34 (11), pp.929-935. ⟨10.1051/medsci/2018238⟩. ⟨inserm-02350074⟩
  • Andrea Popelová, Veronika Pražienková, Barbora Neprašová, Barbora Judita Kasperová, Lucie Hrubá, et al.. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy. Journal of Alzheimer's Disease, IOS Press, 2018, 62 (4), pp.1725-1736. ⟨10.3233/JAD-171041⟩. ⟨hal-03093235⟩
  • Aurélie Joly-Amado, Maud Gratuze, Hamza Benderradji, Didier D. Vieau, Luc Buée, et al.. Relation mutuelle entre Tau et signalisation centrale de l’insuline. médecine/sciences, EDP Sciences, 2018, 34 (11), pp.929-935. ⟨10.1051/medsci/2018238⟩. ⟨inserm-01958478⟩
  • Annerieke Sierksma, Ashley Lu, Evgenia Salta, Elke Vanden Eynden, Zsuzsanna Callaerts-Vegh, et al.. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Molecular Neurodegeneration, BioMed Central, 2018, 13 (1), pp.54. ⟨10.1186/s13024-018-0285-1⟩. ⟨inserm-01930483⟩
  • Chia-Chia Lee, Ching-Pang Chang, Chun-Jung Lin, Hsing-Lin Lai, Yu-Han Kao, et al.. Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer’s Disease. Molecular Neurobiology, Humana Press, 2018, ⟨10.1007/s12035-018-1030-z⟩. ⟨inserm-01833298⟩
  • Lucrezia Cellai, Kevin Carvalho, Emilie Faivre, Aude Deleau, Didier D. Vieau, et al.. The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease. Frontiers in Neuroscience, Frontiers, 2018, 12, pp.520. ⟨10.3389/fnins.2018.00520⟩. ⟨inserm-02350079⟩
  • Pauline Vercruysse, Didier Vieau, David Blum, Åsa Petersén, Luc Dupuis. Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism. Frontiers in Molecular Neuroscience, Frontiers Media, 2018, 11, ⟨10.3389/fnmol.2018.00002⟩. ⟨inserm-01833308⟩
  • David Blum, Yijuang Chern, Maria Rosaria Domenici, Luc Buée, Chien-Yu Lin, et al.. The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease. Journal of Caffeine and Adenosine Research, New Rochelle, N.Y. : Mary Ann Liebert, Inc., [2018]-, 2018, 8 (2), pp.43 - 58. ⟨10.1089/caff.2018.0006⟩. ⟨inserm-01930490⟩
  • Mariana Ferreira, Diana Ferreira, Vânia Batalha, Inês Marques-Morgado, Joana Coelho, et al.. Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors. Molecular Psychiatry, Nature Publishing Group, 2018, ⟨10.1038/s41380-018-0110-9⟩. ⟨inserm-01833281⟩
  • Maud Gratuze, Aurélie Joly-Amado, Didier Vieau, Luc Buée, David Blum. Mutual relationship between Tau and central insulin signalling: consequences for AD and Tauopathies ?. Neuroendocrinology, Karger, 2018, ⟨10.1159/000487641⟩. ⟨inserm-01833302⟩
  • Cyrille Vandenbussche, Cynthia van Der Hauwaert, Edmone Dewaeles, Jessica Franczak, Marie-Flore Mari, et al.. Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulation. Archives of Toxicology, Springer Verlag, 2018, 92 (4), pp.1539 - 1550. ⟨10.1007/s00204-018-2158-3⟩. ⟨inserm-01833311⟩
  • Snehajyoti Chatterjee, Raphaelle Cassel, Anne Schneider‐anthony, Karine Mérienne, Brigitte Cosquer, et al.. Reinstating plasticity and memory in a tauopathy mouse model with an acetyltransferase activator. EMBO Molecular Medicine, Wiley Open Access, 2018, 10 (11), pp.e8587. ⟨10.15252/emmm.201708587⟩. ⟨inserm-01930486⟩
  • Luc Cellai, Kevin Carvalho, Emilie Faivre, Aude Deleau, Didier Vieau, et al.. The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease. Frontiers in Neuroscience, Frontiers, 2018, 12, pp.520. ⟨10.3389/fnins.2018.00520⟩. ⟨inserm-01930487⟩
  • Cyril Laurent, Luc Buée, David Blum. Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?. Biomedical journal, Elsevier, 2018, 41 (1), pp.21 - 33. ⟨10.1016/j.bj.2018.01.003⟩. ⟨inserm-01833293⟩
  • Annerieke Sierksma, Ashley Lu, Evgenia Salta, Elke Vanden Eynden, Zsuzsanna Callaerts-Vegh, et al.. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Molecular Neurodegeneration, BioMed Central, 2018, 13 (1), pp.54. ⟨10.1186/s13024-018-0285-1⟩. ⟨inserm-02350076⟩
  • Emilie Faivre, Joana Coelho, Katja Zornbach, Enas Malik, Younis Baqi, et al.. Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease. Frontiers in Molecular Neuroscience, Frontiers Media, 2018, 11, pp.235. ⟨10.3389/fnmol.2018.00235⟩. ⟨inserm-01930489⟩
  • Cyril Laurent, Guillaume Dorothee, Stéphane Hunot, Elodie Martin, Cecile Delarasse, et al.. Tau et troubles cognitifs. médecine/sciences, EDP Sciences, 2017, 33 (10), pp.817 - 819. ⟨10.1051/medsci/20173310002⟩. ⟨inserm-01833339⟩
  • Romain Duroux, Nicolas Renault, Joana Esteves, Laurence Agouridas, David Blum, et al.. Design, synthesis and evaluation of 2-aryl benzoxazoles as promising hit for the A2A receptor. Journal of Enzyme Inhibition and Medicinal Chemistry, Informa Healthcare, 2017, 32 (1), pp.850-864. ⟨10.1080/14756366.2017.1334648⟩. ⟨hal-02060508⟩
  • Jean-Baptiste Gibier, Brigitte Hemon, Melanie Fanchon, Kelly Gaudelot, Nicolas Pottier, et al.. Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phase. Biochimica et Biophysica Acta - Molecular Basis of Disease, Elsevier, 2017, 1863 (6), pp.1336 - 1349. ⟨10.1016/j.bbadis.2017.03.023⟩. ⟨inserm-01833348⟩
  • Ioannis Sotiropoulos, Marie-Christine Galas, Joana Silva, Efthimios Skoulakis, Susanne Wegmann, et al.. Atypical, non-standard functions of the microtubule associated Tau protein. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2017, 5 (1), ⟨10.1186/s40478-017-0489-6⟩. ⟨hal-03093243⟩
  • Elodie Marciniak, Antoine Leboucher, Emilie Caron, Tariq Ahmed, Anne Tailleux, et al.. Tau deletion promotes brain insulin resistance. Journal of Experimental Medicine, Rockefeller University Press, 2017, 214 (8), pp.2257 - 2269. ⟨10.1084/jem.20161731⟩. ⟨inserm-01833342⟩
  • Ioannis Sotiropoulos, Marie-Christine Galas, Joana Silva, Efthimios Skoulakis, Susanne Wegmann, et al.. Atypical, non-standard functions of the microtubule associated Tau protein. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2017, 5 (1), ⟨10.1186/s40478-017-0489-6⟩. ⟨inserm-01833336⟩
  • Wesley Chen, Edsel Abud, Stephen Yeung, Anita Lakatos, Trevor Nassi, et al.. Increased tauopathy drives microglia-mediated clearance of beta-amyloid. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2016, 4 (1), ⟨10.1186/s40478-016-0336-1⟩. ⟨inserm-01833353⟩
  • Vânia Batalha, Diana Ferreira, Joana Coelho, Jorge Valadas, Rui Gomes, et al.. The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Scientific Reports, Nature Publishing Group, 2016, 6 (1), ⟨10.1038/srep31493⟩. ⟨inserm-01833352⟩
  • Véronique Paban, Béatrice Loriod, Claude Villard, Luc Buee, David Blum, et al.. Omics analysis of mouse brain models of human diseases. Gene, Elsevier, 2016, 600, pp.90 - 100. ⟨10.1016/j.gene.2016.11.022⟩. ⟨hal-01433082⟩
  • Ioannis Sotiropoulos, Marie-Christine Galas, Joana M. Silva, Efthimios Skoulakis, Susanne Wegmann, et al.. Atypical, non-standard functions of the microtubule associated Tau protein. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2016, 5 (1), pp.91. ⟨10.1186/s40478-017-0489-6⟩. ⟨inserm-01654098⟩
  • Cyril Laurent, Guillaume Dorothee, Stéphane Hunot, Elodie Martin, Yann Monnet, et al.. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain - A Journal of Neurology , Oxford University Press (OUP), 2016, 140 (1), pp.184 - 200. ⟨10.1093/brain/aww270⟩. ⟨inserm-01833350⟩
  • Vânia Batalha, Diana Ferreira, Joana Coelho, Jorge Valadas, Rui Gomes, et al.. mRNA Levels of ACh-Related Enzymes in the Hippocampus of THY-Tau22 Mouse: A Model of Human Tauopathy with No Signs of Motor Disturbance. Journal of Molecular Neuroscience, Humana Press, 2016, 58 (4), pp.411-415. ⟨10.1007/s12031-015-0699-y⟩. ⟨hal-02541224⟩
  • Maxime Derisbourg, Coline Leghay, Giovanni Chiappetta, Francisco-Jose Fernandez-Gomez, Cyril Laurent, et al.. Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms. Scientific Reports, Nature Publishing Group, 2015, 5 (1), ⟨10.1038/srep09659⟩. ⟨hal-01659458⟩
  • Valeria Moas Heloire, Nicolas Renault, Vânia Batalha, Angela Rincon Arias, Mathieu Marchivie, et al.. Design and synthesis of fused tetrahydroisoquinoline-iminoimidazolines. European Journal of Medicinal Chemistry, Elsevier, 2015, 106, pp.15-25. ⟨10.1016/j.ejmech.2015.10.030⟩. ⟨hal-02060788⟩
  • Sophie Ayciriex, Marie-Anne Burlot, Jérome Braudeau, Kristin Michaelsen-Preusse, Brigitte Potier, et al.. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology. Human Molecular Genetics, Oxford University Press (OUP), 2015, 24 (21), pp.5965 - 5976. ⟨10.1093/hmg/ddv268⟩. ⟨hal-01779042⟩
  • Amina Chaalal, Roseline Poirier, David Blum, Brigitte Gillet, Pascale Le Blanc, et al.. PTU-induced hypothyroidism in rats leads to several early neuropathological signs of Alzheimer's disease in the hippocampus and spatial memory impairments.. Hippocampus, Wiley, 2014, 24 (11), pp.1381-93. ⟨10.1002/hipo.22319⟩. ⟨hal-01165538⟩
  • Kunie Ando, Pierre Dourlen, Anne-Véronique Sambo, Alexis Bretteville, Karim Bélarbi, et al.. Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker.. Neurobiol Aging, 2013, 34 (3), pp.757-69. ⟨10.1016/j.neurobiolaging.2012.08.004⟩. ⟨hal-00765859⟩
  • Laëticia Troquier, Raphaëlle Caillierez, Sylvie Burnouf, Francisco J. Fernandez-Gomez, Marie-Eve Grosjean, et al.. Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach.: Active Tau immunotherapy. Curr Alzheimer Res, 2012, 9 (4), pp.397-405. ⟨inserm-00664452⟩
  • Luc Buée, David Blum, Stephanie Bombois, Valérie Buée-Scherrer, Marie-Laure Caillet-Boudin, et al.. Comment les acteurs moléculaires de la pathologie Alzheimer permettent de comprendre la démence ? Quelles conséquences diagnostiques et thérapeutiques ?. Alternative and Complementary Therapies, Mary Ann Liebert, 2010, 65 (5), pp.401-407. ⟨10.2515/therapie/2010054⟩. ⟨hal-03093376⟩
  • Sébastien Feuillette, Vincent Deramecourt, Annie Laquérriere, Charles Duyckaerts, Marie-Bernadette Delisle, et al.. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains. Brain Research, Elsevier, 2010, 1345, pp.182-189. ⟨10.1016/j.brainres.2010.05.007⟩. ⟨hal-02329958⟩
  • Karim Belarbi, Katharina Schindowski, Sylvie Burnouf, Raphaëlle Caillierez, Marie-Eve Grosjean, et al.. Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease.. Current Alzheimer Research, Bentham Science Publishers, 2009, 6 (2), pp.152-7. ⟨inserm-00375282⟩
  • David Blum, Fiona J. Hemming, Marie-Christine Galas, Sakina Torch, Laetitia Cuvelier, et al.. Increased Alix (apoptosis-linked gene-2 interacting protein X) immunoreactivity in the degenerating striatum of rats chronically treated by 3-nitropropionic acid.. Neuroscience Letters, Elsevier, 2004, 368 (3), pp.309-13. ⟨10.1016/j.neulet.2004.07.046⟩. ⟨inserm-00381837⟩

Book sections2 documents